Both in Pharmaceuticals
Wave Life Sciences vs ArriVent BioPharma
Over the past year WVE returned −60.3% and AVBP returned −20.6%; their daily moves had a correlation of 0.14.
WVE −60.3% AVBP −20.6%Growth of $1, one year, split-adjusted
| Metric | WVE | AVBP |
|---|---|---|
| Price | $3.59 | $14.87 |
| Market cap | $708.1M | $733.2M |
| Today | −1.10% | −6.77% |
| 1 month | −7.5% | −48.6% |
| 6 months | −51.0% | −50.4% |
| Year to date | −78.9% | −26.1% |
| 1 year | −56.5% | −20.4% |
| Revenue growth (YoY) | +72.9% | — |
| Gross margin | 100.0% | — |
| Net margin | −470.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 10.0× | — |
| Net cash | $430.7M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 62.8% | 153.2% |
| Short % of float | 17.0% | 20.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).